[Treatment of shock (peripheral circulatory insufficiency). II].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001803:Blood Transfusion; D002648:Child; D002675:Child, Preschool; D003911:Dextrans / Q000627:therapeutic use; D004088:Dihydroergotoxine / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D007545:Isoproterenol / Q000627:therapeutic use; D008680:Metaraminol / Q000627:therapeutic use; D009638:Norepinephrine / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D012769:Shock / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D003911:Dextrans; D004088:Dihydroergotoxine; D008680:Metaraminol; D007545:Isoproterenol; D006854:Hydrocortisone; D009638:Norepinephrine; D004837:Epinephrine
Tratamentul şocului (insuficienţa circulatorie periferică). Partea a II-a.